FDA Approves Xarelto (rivaroxaban) to Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery
Links shared publicly online about this topic.
- 177total visits
FDA Approves Xarelto (rivaroxaban) to Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery
View full resource at drugs.com
Tags: Circulatory Disorders, Deep Venous Thrombosis, Knee Pain, Thrombotic Event, FDA, Anti-Clotting Medication, Xarelto
Most Recently Shared on July 2, 2011 at 12:12 am By:
FDA Approves Xarelto to Prevent DVT in Patients Undergoing Knee or Hip Replacement Surgery - http://bit.ly/kRHVxu
Xarelto Approved for Prevention of DVT - ONA
oncologynurseadvisor.com — “Janssen Pharmaceuticals announced FDA approval of Xarelto (rivaroxaban) tablets for the prevention of deep vein thrombosis (DVT) that may lead to a pulmonary embolism (PE) in people undergoing knee or hip replacement surgery.” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 5, 2011 at 4:00 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Xarelto Approved for Prevention of DVT http://goo.gl/fb/nClF6
Xarelto Approved for Prevention of DVT - MPR
empr.com — “Janssen Pharmaceuticals announced FDA approval of Xarelto (rivaroxaban) tablets for the prevention of deep vein thrombosis (DVT) that may lead to a pulmonary embolism (PE) in people undergoing knee or hip replacement surgery.” View full resource at empr.com
Most Recently Shared on July 5, 2011 at 3:50 pm By:
MPR News: Xarelto Approved for Prevention of DVT: Janssen Pharmaceuticals announced FDA approval of Xarelto (riv... http://bit.ly/iUhU2J
Bayer HealthCare - FDA Approves Xarelto® (rivaroxaban tablets) for the Prophylaxis of Deep Vein Thrombosis Which May Lead to a Pulmonary Embolism in Patients Undergoing Knee or Hip Replacement Surgery
press.bayerhealthcare.com — “Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry. The company combines the global activities of the divisions Animal Health, Bayer Schering Pharma, Consumer Care and Diabetes Care. More than 50,000 people are employed by Bayer HealthCare worldwide. Our aim is to discover and manufacture innovative products that will improve human and animal health worldwide. Our products enhance well-being and quality ” View full resource at press.bayerhealthcare.com
Most Recently Shared on July 3, 2011 at 6:25 pm By:
FDA Approves Xarelto® for the Prophylaxis of Deep Vein Thrombosis ......... http://t.co/yn1AQsl
Once-Daily Anticoagulant Xarelto Approved By FDA For DVT Prevention - QualityPoint Technologies
qualitypointtech.net — “Blood thinner (anticoagulant) Xarelto (rivaroxaban tablets) has been approved by the FDA (Food and Drug Administration) for the prevention of DVT (deep vein thrombosis) in patients who had knee or hip replacement surgery. The tablets are taken once daily. According to Xarelto makers, Janssen Pharmaceuticals, Inc., about 80,000 patients in the USA undergo hip or knee replacement surgery every year, the majority of them are aged 50+ years and suffer from arthritis. They have a significantly higher” View full resource at qualitypointtech.net
Most Recently Shared on July 3, 2011 at 3:45 am By:
Once-Daily Anticoagulant Xarelto Approved By FDA For DVT Prevention: Blood thinner (anticoagulant) Xarelto (rivaro... http://bit.ly/iogCch
Once-Daily Anticoagulant Xarelto Approved By FDA For DVT Prevention - QualityPoint Technologies
qualitypointtech.net — “Blood thinner (anticoagulant) Xarelto (rivaroxaban tablets) has been approved by the FDA (Food and Drug Administration) for the prevention of DVT (deep vein thrombosis) in patients who had knee or hip replacement surgery. The tablets are taken once daily. According to Xarelto makers, Janssen Pharmaceuticals, Inc., about 80,000 patients in the USA undergo hip or knee replacement surgery every year, the majority of them are aged 50+ years and suffer from arthritis. They have a significantly higher” View full resource at qualitypointtech.net
Most Recently Shared on July 2, 2011 at 5:45 pm By:
Once-Daily Anticoagulant Xarelto Approved By FDA For DVT Prevention: Blood thinner (anticoagulant) Xarelto (rivaro... http://bit.ly/kwisgY
FDA Approves Xarelto (rivaroxaban) to Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery
drugs.com — “Xarelto (rivaroxaban) is used for the prevention of deep vein thrombosis (DVT) in people undergoing knee or hip replacement surgery. Includes Xarelto side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 2, 2011 at 12:11 am By:
Drugs and Devices OW OW Health
FDA Approves Xarelto (rivaroxaban) to Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Repl... http://bit.ly/ly2tvl #drug
Rivaroxaban (Xarelto) Gains First FDA Approval for DVT Prevention - Larry Husten - Cardiobrief - Forbes
blogs.forbes.com — “Rivaroxaban(Xarelto, Janssen) received FDA approval today for the prevention of deep vein thrombosis which may lead to a pulmonary embolism in patients undergoing knee or hip replacement surgery. The drug is a once-daily oral anticoagulant and has been approved for use at a 10 mg dose, once-daily for 35 days [...]” View full resource at blogs.forbes.com
Most Recently Shared on July 1, 2011 at 10:22 pm By:
Drugs and Devices OW OW Health
Rivaroxaban (Xarelto) Gains First FDA Approval for DVT Prevention: Rivaroxaban(Xarelto, Janssen) receiv... http://onforb.es/lPaAi7 #drug
Medical News: Rivaroxaban Wins FDA Approval for DVT Prevention - in Cardiovascular, Prevention from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved rivaroxaban (Xarelto), an oral, once-daily, factor Xa inhibitor, for prevention of deep vein thrombosis in patients undergoing knee or hip replacement surgery, accor” View full resource at medpagetoday.com
Most Recently Shared on July 1, 2011 at 10:09 pm By:
Patricia Grace Eldercare Expert
Rivaroxaban Wins FDA Approval for DVT Prevention: WASHINGTON (MedPage Today) -- The FDA has approved rivaroxaban... http://bit.ly/mzfsbF
Advertisement
